Short-term oral treatment of vulvovaginal candidosis: A survey of patient preference;Die orale kurzzeit-therapie der vulvovaginalen pilzinfektion als ein patientenorientiertes therapiekonzept

Geburtshilfe und Frauenheilkunde

Volumn 61, Issue 3, 2001, Pages 133-137

  Kiss, H ^a   Witt, A ^a   Petricevic, L ^a   Riedl, A M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ADULT; ARTICLE; CANDIDIASIS; CLINICAL PRACTICE; DRUG PREFERENCE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; QUESTIONNAIRE; SUPPOSITORY; TABLET FORMULATION; VAGINITIS; VULVITIS;

EID: 0035068457     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-11899     Document Type: Article

References (13)

1. ACOG, Technical Bulletin
2. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis
3. Recurrent Candida infection
4. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species
5. Epidemiology of vaginitis
6. Oral versus local treatment of vaginal candidosis
7. Treatment of vaginal candidiasis: Orally or vaginally?
8. One-day therapy for vaginal candidiasis
9. A single-blind comparison of oral and intravaginal treatments in acute and recurrent candidosis in general practice
10. Managing recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole
11. Testing susceptibility of Candida species to fiuconazole and itraconazole using the microdilution assay
12. Pharmacokinetics of oral antifungals and their clinical implications
13. Patient and doctor preferences in the treatment of vaginal candidosis